Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lyme Disease | 31 | 2021 | 104 | 5.340 |
Why?
|
Borrelia burgdorferi | 15 | 2021 | 67 | 2.720 |
Why?
|
Neutrophils | 44 | 1998 | 351 | 1.680 |
Why?
|
Borrelia burgdorferi Group | 18 | 2015 | 27 | 1.660 |
Why?
|
Antibodies, Monoclonal | 13 | 2023 | 865 | 1.530 |
Why?
|
Lipoproteins | 6 | 2021 | 85 | 1.400 |
Why?
|
Bacterial Vaccines | 5 | 2021 | 90 | 1.310 |
Why?
|
Bacterial Outer Membrane Proteins | 5 | 2021 | 137 | 1.300 |
Why?
|
Enterotoxigenic Escherichia coli | 7 | 2023 | 22 | 1.240 |
Why?
|
Anti-Bacterial Agents | 11 | 2013 | 718 | 1.210 |
Why?
|
Antibodies, Bacterial | 12 | 2023 | 192 | 1.080 |
Why?
|
Matrix Metalloproteinase 9 | 7 | 2007 | 58 | 1.000 |
Why?
|
Antigens, Surface | 5 | 2021 | 190 | 0.940 |
Why?
|
Disease Transmission, Infectious | 2 | 2016 | 20 | 0.800 |
Why?
|
Immunoglobulin A, Secretory | 6 | 2023 | 22 | 0.800 |
Why?
|
Escherichia coli Infections | 6 | 2023 | 87 | 0.770 |
Why?
|
Plasminogen | 5 | 1997 | 7 | 0.670 |
Why?
|
Immunoglobulin A | 5 | 2022 | 93 | 0.620 |
Why?
|
DNA, Bacterial | 1 | 2019 | 259 | 0.580 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2019 | 217 | 0.560 |
Why?
|
Skin | 3 | 2010 | 350 | 0.560 |
Why?
|
Lysosomes | 13 | 1988 | 162 | 0.550 |
Why?
|
Ceftriaxone | 4 | 2003 | 19 | 0.540 |
Why?
|
Pre-Exposure Prophylaxis | 1 | 2016 | 22 | 0.510 |
Why?
|
Humans | 112 | 2023 | 59078 | 0.510 |
Why?
|
Escherichia coli Vaccines | 3 | 2021 | 11 | 0.510 |
Why?
|
Immunologic Factors | 1 | 2016 | 99 | 0.500 |
Why?
|
Monocytes | 3 | 2007 | 351 | 0.490 |
Why?
|
Erythema Chronicum Migrans | 2 | 2005 | 9 | 0.480 |
Why?
|
Up-Regulation | 2 | 2007 | 362 | 0.460 |
Why?
|
Calcium | 8 | 1988 | 550 | 0.460 |
Why?
|
Doxycycline | 4 | 2003 | 41 | 0.440 |
Why?
|
Serologic Tests | 2 | 2012 | 34 | 0.440 |
Why?
|
Fibroblasts | 3 | 2007 | 366 | 0.430 |
Why?
|
Communicable Diseases | 3 | 2007 | 81 | 0.430 |
Why?
|
Immunoglobulin G | 11 | 2022 | 450 | 0.410 |
Why?
|
Disasters | 2 | 2005 | 28 | 0.410 |
Why?
|
Animals | 34 | 2022 | 19554 | 0.390 |
Why?
|
Urokinase-Type Plasminogen Activator | 3 | 1996 | 10 | 0.390 |
Why?
|
Single-Domain Antibodies | 2 | 2022 | 16 | 0.390 |
Why?
|
Diarrhea | 3 | 2021 | 73 | 0.380 |
Why?
|
Clindamycin | 7 | 1996 | 13 | 0.380 |
Why?
|
Immunization, Passive | 4 | 2023 | 100 | 0.380 |
Why?
|
Bacillus anthracis | 1 | 2010 | 12 | 0.360 |
Why?
|
Intestinal Diseases | 1 | 2010 | 34 | 0.350 |
Why?
|
Mice, Inbred C3H | 3 | 2019 | 174 | 0.330 |
Why?
|
Lipopolysaccharide Receptors | 2 | 2007 | 143 | 0.310 |
Why?
|
Antibodies, Neutralizing | 3 | 2021 | 192 | 0.310 |
Why?
|
Epitopes | 7 | 2022 | 299 | 0.300 |
Why?
|
Chronic Disease | 8 | 2013 | 731 | 0.300 |
Why?
|
Disease Vectors | 1 | 2007 | 7 | 0.290 |
Why?
|
Disease Reservoirs | 1 | 2007 | 8 | 0.290 |
Why?
|
Leishmaniasis, Visceral | 1 | 2007 | 11 | 0.290 |
Why?
|
Macrophages | 7 | 1991 | 1003 | 0.290 |
Why?
|
Chemokine CCL2 | 1 | 2007 | 54 | 0.280 |
Why?
|
Specialization | 2 | 1999 | 73 | 0.280 |
Why?
|
Communicable Disease Control | 1 | 2007 | 38 | 0.280 |
Why?
|
Drug Therapy, Combination | 4 | 2003 | 433 | 0.270 |
Why?
|
Mice | 17 | 2022 | 10232 | 0.270 |
Why?
|
HLA-DR Antigens | 2 | 2005 | 27 | 0.260 |
Why?
|
Escherichia coli | 6 | 2013 | 676 | 0.260 |
Why?
|
Superoxides | 11 | 1998 | 69 | 0.260 |
Why?
|
Communicable Diseases, Emerging | 1 | 2006 | 22 | 0.260 |
Why?
|
Disease Outbreaks | 2 | 2016 | 105 | 0.250 |
Why?
|
Cholera Vaccines | 1 | 2005 | 3 | 0.250 |
Why?
|
Haplotypes | 1 | 2005 | 117 | 0.250 |
Why?
|
Cholera | 1 | 2005 | 11 | 0.250 |
Why?
|
Ticks | 3 | 2021 | 30 | 0.240 |
Why?
|
Administration, Oral | 6 | 2023 | 344 | 0.240 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2005 | 179 | 0.240 |
Why?
|
Zoonoses | 1 | 2004 | 7 | 0.230 |
Why?
|
Public Health | 1 | 2006 | 180 | 0.230 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2004 | 24 | 0.230 |
Why?
|
Gelatinases | 3 | 1998 | 9 | 0.220 |
Why?
|
Lyme Neuroborreliosis | 1 | 2003 | 9 | 0.220 |
Why?
|
Spike Glycoprotein, Coronavirus | 2 | 2022 | 97 | 0.220 |
Why?
|
Salmonella typhimurium | 2 | 2013 | 80 | 0.210 |
Why?
|
Biomedical Research | 1 | 2006 | 247 | 0.210 |
Why?
|
Tetanus Toxin | 3 | 1988 | 8 | 0.210 |
Why?
|
Interleukin-2 | 5 | 1998 | 163 | 0.210 |
Why?
|
Rabies Vaccines | 1 | 2022 | 4 | 0.210 |
Why?
|
Rabies | 1 | 2022 | 5 | 0.200 |
Why?
|
Antibody Specificity | 3 | 2020 | 99 | 0.200 |
Why?
|
Rabies virus | 1 | 2022 | 5 | 0.200 |
Why?
|
Babesiosis | 2 | 2006 | 10 | 0.200 |
Why?
|
Chemotaxis, Leukocyte | 13 | 1998 | 59 | 0.200 |
Why?
|
Staphylococcus aureus | 4 | 1988 | 158 | 0.200 |
Why?
|
Antibodies, Viral | 3 | 2022 | 307 | 0.200 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2022 | 41 | 0.190 |
Why?
|
Treatment Outcome | 7 | 2016 | 5129 | 0.190 |
Why?
|
Cognition Disorders | 1 | 2003 | 217 | 0.190 |
Why?
|
Influenza, Human | 1 | 2004 | 193 | 0.190 |
Why?
|
Autoimmunity | 3 | 1999 | 223 | 0.190 |
Why?
|
Metalloendopeptidases | 2 | 1998 | 22 | 0.190 |
Why?
|
Serology | 1 | 2001 | 1 | 0.190 |
Why?
|
Kinetics | 12 | 1996 | 732 | 0.190 |
Why?
|
Synovial Fluid | 3 | 2001 | 29 | 0.190 |
Why?
|
Urinalysis | 1 | 2001 | 33 | 0.190 |
Why?
|
Mice, SCID | 2 | 2019 | 501 | 0.180 |
Why?
|
Historiography | 1 | 2000 | 2 | 0.180 |
Why?
|
Holocaust | 1 | 2000 | 2 | 0.180 |
Why?
|
Male | 27 | 2021 | 27399 | 0.180 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 40 | 0.180 |
Why?
|
Escherichia coli Proteins | 2 | 2021 | 251 | 0.180 |
Why?
|
HEK293 Cells | 2 | 2020 | 567 | 0.180 |
Why?
|
Bacterial Proteins | 5 | 2004 | 739 | 0.180 |
Why?
|
Phagocytosis | 15 | 1998 | 252 | 0.170 |
Why?
|
Female | 23 | 2019 | 30709 | 0.170 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 7 | 1988 | 17 | 0.170 |
Why?
|
Plasmids | 3 | 2019 | 279 | 0.170 |
Why?
|
Adult | 28 | 2015 | 15680 | 0.160 |
Why?
|
Antigens, Bacterial | 4 | 2001 | 211 | 0.160 |
Why?
|
Mice, Transgenic | 3 | 2021 | 1220 | 0.160 |
Why?
|
Disease Models, Animal | 4 | 2021 | 2053 | 0.160 |
Why?
|
Muramidase | 9 | 1998 | 47 | 0.160 |
Why?
|
Medicine | 1 | 1999 | 56 | 0.160 |
Why?
|
Betacoronavirus | 1 | 2020 | 159 | 0.160 |
Why?
|
Genes, Bacterial | 2 | 2001 | 117 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 663 | 0.150 |
Why?
|
Cytoplasmic Granules | 9 | 1988 | 53 | 0.150 |
Why?
|
In Vitro Techniques | 10 | 2015 | 473 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 9 | 2020 | 427 | 0.150 |
Why?
|
Transfection | 2 | 2019 | 671 | 0.150 |
Why?
|
Tetradecanoylphorbol Acetate | 5 | 1988 | 67 | 0.150 |
Why?
|
Family Practice | 1 | 1999 | 204 | 0.140 |
Why?
|
Cells, Cultured | 8 | 2007 | 2092 | 0.140 |
Why?
|
Host-Parasite Interactions | 1 | 1997 | 54 | 0.140 |
Why?
|
Polymers | 1 | 2020 | 315 | 0.140 |
Why?
|
Nervous System Diseases | 1 | 1998 | 94 | 0.140 |
Why?
|
Double-Blind Method | 6 | 2004 | 683 | 0.140 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 60 | 0.140 |
Why?
|
alpha-2-Antiplasmin | 1 | 1996 | 1 | 0.130 |
Why?
|
Plasminogen Activator Inhibitor 2 | 1 | 1996 | 2 | 0.130 |
Why?
|
Fibrinolysis | 1 | 1996 | 5 | 0.130 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 1996 | 14 | 0.130 |
Why?
|
Borrelia | 1 | 1996 | 25 | 0.130 |
Why?
|
Tick Bites | 1 | 2016 | 9 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 4 | 1992 | 238 | 0.130 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 67 | 0.130 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2016 | 24 | 0.130 |
Why?
|
Nanoparticles | 2 | 2020 | 496 | 0.130 |
Why?
|
Ebolavirus | 1 | 2016 | 34 | 0.130 |
Why?
|
Aged | 15 | 2015 | 13267 | 0.130 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 436 | 0.120 |
Why?
|
Viral Envelope Proteins | 1 | 2016 | 107 | 0.120 |
Why?
|
Middle Aged | 14 | 2015 | 16197 | 0.120 |
Why?
|
Receptors, Fc | 1 | 2015 | 21 | 0.120 |
Why?
|
Lymphokines | 3 | 1986 | 66 | 0.120 |
Why?
|
Autoantibodies | 1 | 2015 | 174 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 453 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1999 | 738 | 0.110 |
Why?
|
Neurons | 1 | 1999 | 854 | 0.110 |
Why?
|
Chemotactic Factors | 3 | 1991 | 26 | 0.110 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2015 | 130 | 0.110 |
Why?
|
Interleukin-1 | 3 | 1992 | 154 | 0.110 |
Why?
|
Collagenases | 3 | 1998 | 14 | 0.110 |
Why?
|
Signal Transduction | 2 | 2013 | 2883 | 0.110 |
Why?
|
Mycobacterium Infections | 1 | 1993 | 16 | 0.110 |
Why?
|
BCG Vaccine | 1 | 1993 | 43 | 0.110 |
Why?
|
Cross Reactions | 3 | 2020 | 123 | 0.110 |
Why?
|
Mycobacterium bovis | 1 | 1993 | 27 | 0.110 |
Why?
|
Education, Medical | 1 | 1995 | 175 | 0.110 |
Why?
|
Leukocyte Migration-Inhibitory Factors | 2 | 1983 | 2 | 0.110 |
Why?
|
Mental Disorders | 1 | 2000 | 763 | 0.100 |
Why?
|
Cell Culture Techniques | 2 | 2007 | 176 | 0.100 |
Why?
|
Cell Membrane | 10 | 1996 | 489 | 0.100 |
Why?
|
Treatment Failure | 2 | 2003 | 188 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 2 | 2005 | 673 | 0.100 |
Why?
|
Homeostasis | 3 | 1988 | 340 | 0.090 |
Why?
|
Methylamines | 2 | 1988 | 6 | 0.090 |
Why?
|
History, 20th Century | 2 | 2004 | 226 | 0.090 |
Why?
|
Receptors, Immunologic | 3 | 1988 | 177 | 0.090 |
Why?
|
Caco-2 Cells | 2 | 2021 | 65 | 0.090 |
Why?
|
Ascites | 1 | 2010 | 21 | 0.090 |
Why?
|
Shock | 1 | 2010 | 31 | 0.090 |
Why?
|
Yersinia pestis | 2 | 1990 | 33 | 0.090 |
Why?
|
Acute Disease | 2 | 2003 | 654 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 894 | 0.090 |
Why?
|
Nerve Tissue | 1 | 2010 | 4 | 0.090 |
Why?
|
Case-Control Studies | 2 | 2005 | 1054 | 0.090 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2010 | 34 | 0.090 |
Why?
|
Hypotension | 1 | 2010 | 47 | 0.090 |
Why?
|
Cytosol | 5 | 1988 | 167 | 0.090 |
Why?
|
Ammonium Chloride | 5 | 1988 | 10 | 0.090 |
Why?
|
Hematoma | 1 | 2010 | 74 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 1993 | 256 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2010 | 92 | 0.090 |
Why?
|
Granulomatous Disease, Chronic | 2 | 1991 | 39 | 0.080 |
Why?
|
Protein Binding | 3 | 2020 | 1542 | 0.080 |
Why?
|
Oxygen Consumption | 6 | 1988 | 197 | 0.080 |
Why?
|
Cytochalasin B | 2 | 1987 | 23 | 0.080 |
Why?
|
Music | 1 | 2010 | 76 | 0.080 |
Why?
|
Pyrogens | 2 | 1979 | 2 | 0.080 |
Why?
|
Binding Sites | 5 | 2016 | 872 | 0.080 |
Why?
|
Leukotriene B4 | 1 | 1988 | 13 | 0.080 |
Why?
|
Staphylococcal Skin Infections | 1 | 1988 | 13 | 0.080 |
Why?
|
Chediak-Higashi Syndrome | 1 | 1988 | 3 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 127 | 0.080 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1988 | 33 | 0.080 |
Why?
|
Tetanus | 1 | 1988 | 5 | 0.080 |
Why?
|
Propranolol | 1 | 1988 | 22 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2001 | 807 | 0.080 |
Why?
|
Alprenolol | 1 | 1988 | 1 | 0.080 |
Why?
|
Dihydroalprenolol | 1 | 1988 | 1 | 0.080 |
Why?
|
Propanolamines | 1 | 1988 | 10 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 1 | 1988 | 28 | 0.080 |
Why?
|
Azides | 1 | 1988 | 19 | 0.080 |
Why?
|
Phagosomes | 1 | 1988 | 44 | 0.070 |
Why?
|
Ion Channels | 1 | 1988 | 86 | 0.070 |
Why?
|
Blotting, Western | 3 | 2015 | 592 | 0.070 |
Why?
|
Cell Fractionation | 3 | 1985 | 31 | 0.070 |
Why?
|
Protein Kinase C | 1 | 1988 | 98 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2001 | 280 | 0.070 |
Why?
|
Paromomycin | 1 | 2007 | 1 | 0.070 |
Why?
|
Psychodidae | 1 | 2007 | 1 | 0.070 |
Why?
|
Antiprotozoal Agents | 1 | 2007 | 8 | 0.070 |
Why?
|
Leukocytes | 3 | 1991 | 107 | 0.070 |
Why?
|
U937 Cells | 1 | 2007 | 9 | 0.070 |
Why?
|
Hypersensitivity | 1 | 1988 | 60 | 0.070 |
Why?
|
Molecular Weight | 2 | 1997 | 187 | 0.070 |
Why?
|
Bacterial Adhesion | 2 | 2021 | 59 | 0.070 |
Why?
|
Spinal Cord | 1 | 1988 | 195 | 0.070 |
Why?
|
Vero Cells | 2 | 2020 | 74 | 0.070 |
Why?
|
Anaplasmosis | 1 | 2006 | 4 | 0.070 |
Why?
|
Autoantigens | 2 | 2015 | 125 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 2 | 1998 | 75 | 0.070 |
Why?
|
L-Lactate Dehydrogenase | 5 | 1998 | 28 | 0.070 |
Why?
|
Oxacillin | 2 | 1986 | 3 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 1997 | 61 | 0.070 |
Why?
|
Tick-Borne Diseases | 1 | 2006 | 7 | 0.070 |
Why?
|
Operon | 2 | 2004 | 32 | 0.070 |
Why?
|
Antibody Formation | 2 | 2016 | 111 | 0.070 |
Why?
|
Kidney Neoplasms | 2 | 1998 | 114 | 0.070 |
Why?
|
Rifampin | 1 | 1986 | 23 | 0.070 |
Why?
|
Bioterrorism | 1 | 2006 | 11 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2003 | 1466 | 0.070 |
Why?
|
Oligopeptides | 2 | 2004 | 131 | 0.070 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2005 | 28 | 0.060 |
Why?
|
Vaccines | 1 | 2007 | 96 | 0.060 |
Why?
|
Vancomycin | 1 | 1986 | 35 | 0.060 |
Why?
|
HLA-DQ beta-Chains | 1 | 2005 | 3 | 0.060 |
Why?
|
HLA-DRB1 Chains | 1 | 2005 | 12 | 0.060 |
Why?
|
HLA-DQ Antigens | 1 | 2005 | 14 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 1997 | 880 | 0.060 |
Why?
|
Disaster Planning | 1 | 2006 | 51 | 0.060 |
Why?
|
Thiazoles | 1 | 1985 | 47 | 0.060 |
Why?
|
Asia, Southeastern | 1 | 2005 | 5 | 0.060 |
Why?
|
Water Supply | 1 | 2005 | 13 | 0.060 |
Why?
|
Digitonin | 1 | 1985 | 4 | 0.060 |
Why?
|
Vibrio cholerae | 1 | 2005 | 11 | 0.060 |
Why?
|
Microscopy, Confocal | 2 | 1996 | 219 | 0.060 |
Why?
|
Daunorubicin | 1 | 1984 | 6 | 0.060 |
Why?
|
Bacillus | 1 | 2005 | 13 | 0.060 |
Why?
|
Spectrum Analysis, Raman | 1 | 2005 | 23 | 0.060 |
Why?
|
NADP | 1 | 1984 | 24 | 0.060 |
Why?
|
Complement C6 | 1 | 2004 | 2 | 0.060 |
Why?
|
Boston | 1 | 2006 | 326 | 0.060 |
Why?
|
Models, Molecular | 2 | 2020 | 1114 | 0.060 |
Why?
|
Bacteria, Anaerobic | 1 | 1984 | 5 | 0.060 |
Why?
|
Influenza in Birds | 1 | 2004 | 3 | 0.060 |
Why?
|
Poultry | 1 | 2004 | 9 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 498 | 0.060 |
Why?
|
Alleles | 1 | 2005 | 425 | 0.060 |
Why?
|
Melanoma | 2 | 1998 | 335 | 0.060 |
Why?
|
Leishmania | 1 | 1983 | 11 | 0.060 |
Why?
|
Glucuronidase | 4 | 1998 | 23 | 0.060 |
Why?
|
Blister | 1 | 2003 | 17 | 0.060 |
Why?
|
Genotype | 1 | 2005 | 642 | 0.060 |
Why?
|
Sensation Disorders | 1 | 2003 | 21 | 0.050 |
Why?
|
Complement C5 | 2 | 1980 | 9 | 0.050 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 170 | 0.050 |
Why?
|
Prognosis | 4 | 2004 | 1563 | 0.050 |
Why?
|
Influenza A virus | 1 | 2004 | 117 | 0.050 |
Why?
|
Cell Line | 1 | 2007 | 2011 | 0.050 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2022 | 6 | 0.050 |
Why?
|
Affect | 1 | 2003 | 121 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2005 | 5062 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 522 | 0.050 |
Why?
|
CHO Cells | 2 | 2019 | 191 | 0.050 |
Why?
|
Calcimycin | 3 | 1988 | 19 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2003 | 338 | 0.050 |
Why?
|
Mutation | 3 | 2020 | 2421 | 0.050 |
Why?
|
Matrix Metalloproteinases | 1 | 2001 | 16 | 0.050 |
Why?
|
Syndrome | 2 | 2015 | 173 | 0.050 |
Why?
|
Macaca fascicularis | 1 | 2021 | 47 | 0.050 |
Why?
|
Injections, Intravenous | 1 | 2001 | 147 | 0.050 |
Why?
|
District of Columbia | 1 | 2001 | 11 | 0.050 |
Why?
|
Cross Protection | 1 | 2021 | 5 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 1998 | 28 | 0.050 |
Why?
|
Camelids, New World | 1 | 2021 | 7 | 0.050 |
Why?
|
Fimbriae Proteins | 1 | 2021 | 13 | 0.050 |
Why?
|
Gastric Acid | 1 | 2021 | 10 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2021 | 18 | 0.050 |
Why?
|
Epitope Mapping | 1 | 2021 | 46 | 0.050 |
Why?
|
Plants, Genetically Modified | 1 | 2021 | 22 | 0.050 |
Why?
|
Dogs | 1 | 2022 | 313 | 0.050 |
Why?
|
Porosity | 1 | 2020 | 37 | 0.050 |
Why?
|
Silicon | 1 | 2020 | 20 | 0.050 |
Why?
|
Gelatin | 1 | 2020 | 28 | 0.050 |
Why?
|
Chromatography, Affinity | 1 | 2020 | 50 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2021 | 84 | 0.040 |
Why?
|
Recombinant Proteins | 4 | 1998 | 691 | 0.040 |
Why?
|
Glycosylation | 1 | 2021 | 134 | 0.040 |
Why?
|
Young Adult | 1 | 2010 | 4303 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 251 | 0.040 |
Why?
|
Fluorescent Dyes | 2 | 1995 | 195 | 0.040 |
Why?
|
Solubility | 1 | 2020 | 173 | 0.040 |
Why?
|
Hydrogen Peroxide | 4 | 1988 | 74 | 0.040 |
Why?
|
Intestine, Small | 1 | 2020 | 72 | 0.040 |
Why?
|
Macaca mulatta | 1 | 2021 | 246 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2021 | 179 | 0.040 |
Why?
|
Aotidae | 1 | 2020 | 9 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2020 | 82 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2001 | 119 | 0.040 |
Why?
|
Phosphates | 1 | 2020 | 88 | 0.040 |
Why?
|
Blood Bactericidal Activity | 3 | 1990 | 70 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2015 | 180 | 0.040 |
Why?
|
Pain | 1 | 2003 | 406 | 0.040 |
Why?
|
Tuftsin | 1 | 1979 | 1 | 0.040 |
Why?
|
gamma-Globulins | 1 | 1979 | 10 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2001 | 1577 | 0.040 |
Why?
|
Drug Design | 1 | 2021 | 143 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2020 | 163 | 0.040 |
Why?
|
Molecular Mimicry | 1 | 1999 | 35 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2004 | 1444 | 0.040 |
Why?
|
Antigen-Antibody Complex | 2 | 2016 | 49 | 0.040 |
Why?
|
Cricetulus | 1 | 2019 | 102 | 0.040 |
Why?
|
Astrocytes | 1 | 1999 | 114 | 0.040 |
Why?
|
Biomarkers | 1 | 2004 | 1202 | 0.040 |
Why?
|
Opsonin Proteins | 3 | 1984 | 31 | 0.040 |
Why?
|
Receptors, Formyl Peptide | 3 | 1988 | 6 | 0.040 |
Why?
|
Drug Stability | 1 | 2019 | 139 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2004 | 714 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 1997 | 384 | 0.040 |
Why?
|
Interleukin-11 | 1 | 1998 | 8 | 0.040 |
Why?
|
Drug Compounding | 1 | 2019 | 74 | 0.040 |
Why?
|
Membrane Proteins | 4 | 1995 | 839 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 171 | 0.040 |
Why?
|
Renal Dialysis | 1 | 1980 | 184 | 0.040 |
Why?
|
Drug Resistance, Microbial | 2 | 2013 | 44 | 0.040 |
Why?
|
Immunotherapy | 1 | 2021 | 225 | 0.040 |
Why?
|
Clinical Enzyme Tests | 1 | 1998 | 8 | 0.040 |
Why?
|
Astrocytoma | 1 | 1998 | 12 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 1998 | 68 | 0.040 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1978 | 48 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 1998 | 64 | 0.040 |
Why?
|
Cell Separation | 1 | 1978 | 147 | 0.040 |
Why?
|
Mice, Inbred AKR | 1 | 1997 | 12 | 0.040 |
Why?
|
Central Nervous System | 1 | 1999 | 190 | 0.040 |
Why?
|
Meningeal Neoplasms | 1 | 1998 | 56 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 1997 | 84 | 0.040 |
Why?
|
Ionomycin | 2 | 1988 | 15 | 0.040 |
Why?
|
Ethers | 2 | 1988 | 17 | 0.040 |
Why?
|
Cell Adhesion | 5 | 1986 | 211 | 0.040 |
Why?
|
Aminoquinolines | 2 | 1988 | 15 | 0.040 |
Why?
|
Th2 Cells | 1 | 1997 | 98 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 1998 | 93 | 0.040 |
Why?
|
Temperature | 3 | 1983 | 300 | 0.040 |
Why?
|
Sequence Alignment | 1 | 1997 | 290 | 0.030 |
Why?
|
Hydrocortisone | 1 | 1978 | 188 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1990 | 580 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2016 | 20 | 0.030 |
Why?
|
Erythrocytes | 3 | 1984 | 153 | 0.030 |
Why?
|
Cytokines | 2 | 1998 | 904 | 0.030 |
Why?
|
Th1 Cells | 1 | 1997 | 170 | 0.030 |
Why?
|
Hyaluronoglucosaminidase | 1 | 1996 | 4 | 0.030 |
Why?
|
Pancreatic Elastase | 1 | 1996 | 31 | 0.030 |
Why?
|
Quinine | 1 | 1996 | 3 | 0.030 |
Why?
|
Fever of Unknown Origin | 1 | 1996 | 3 | 0.030 |
Why?
|
Hot Temperature | 2 | 1988 | 125 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 1997 | 3183 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2001 | 1540 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 1997 | 1972 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2016 | 151 | 0.030 |
Why?
|
Ebola Vaccines | 1 | 2016 | 2 | 0.030 |
Why?
|
Parasitemia | 1 | 1996 | 32 | 0.030 |
Why?
|
Democratic Republic of the Congo | 1 | 2016 | 8 | 0.030 |
Why?
|
Spectrophotometry | 1 | 1996 | 31 | 0.030 |
Why?
|
Depression | 1 | 2003 | 856 | 0.030 |
Why?
|
Azithromycin | 1 | 1996 | 26 | 0.030 |
Why?
|
Rats | 1 | 1999 | 1904 | 0.030 |
Why?
|
Recurrence | 3 | 2004 | 575 | 0.030 |
Why?
|
Chloroquine | 2 | 1986 | 48 | 0.030 |
Why?
|
Antimalarials | 1 | 1996 | 67 | 0.030 |
Why?
|
Antigens, CD | 1 | 1997 | 341 | 0.030 |
Why?
|
Fibrinolysin | 1 | 1995 | 5 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 418 | 0.030 |
Why?
|
Exocytosis | 2 | 1987 | 60 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2015 | 41 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 1998 | 300 | 0.030 |
Why?
|
Tissue Donors | 1 | 2016 | 132 | 0.030 |
Why?
|
Virion | 1 | 2016 | 117 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 1997 | 500 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 1999 | 957 | 0.030 |
Why?
|
Endopeptidases | 1 | 1995 | 65 | 0.030 |
Why?
|
Survivors | 1 | 2016 | 148 | 0.030 |
Why?
|
Half-Life | 1 | 2015 | 70 | 0.030 |
Why?
|
Massachusetts | 1 | 2001 | 2082 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 1998 | 306 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 1997 | 550 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1995 | 137 | 0.030 |
Why?
|
Forecasting | 1 | 1995 | 218 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2005 | 1092 | 0.030 |
Why?
|
Quality of Life | 1 | 2001 | 1103 | 0.030 |
Why?
|
Child | 2 | 2023 | 4260 | 0.030 |
Why?
|
Practice Patterns, Physicians' | 1 | 1999 | 709 | 0.030 |
Why?
|
Helminthiasis | 1 | 2013 | 4 | 0.030 |
Why?
|
Phagocytes | 2 | 1986 | 49 | 0.030 |
Why?
|
Time Factors | 3 | 1986 | 3554 | 0.030 |
Why?
|
Binding, Competitive | 2 | 2004 | 102 | 0.030 |
Why?
|
Administration, Intravesical | 1 | 1993 | 3 | 0.030 |
Why?
|
Rabbits | 4 | 1990 | 330 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 606 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1993 | 103 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1993 | 22 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 1993 | 220 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 1998 | 638 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2010 | 846 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 1992 | 56 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1993 | 60 | 0.030 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 2 | 1982 | 4 | 0.030 |
Why?
|
Gramicidin | 2 | 1982 | 6 | 0.030 |
Why?
|
Laryngeal Neoplasms | 1 | 1992 | 53 | 0.030 |
Why?
|
Culture Media | 1 | 1992 | 77 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1992 | 72 | 0.030 |
Why?
|
Virulence | 3 | 1990 | 189 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 1997 | 403 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1992 | 453 | 0.020 |
Why?
|
Interleukin-8 | 2 | 1998 | 84 | 0.020 |
Why?
|
Serial Passage | 1 | 1991 | 3 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 1991 | 70 | 0.020 |
Why?
|
Urinary Bladder | 1 | 1991 | 34 | 0.020 |
Why?
|
Cell Movement | 3 | 1983 | 420 | 0.020 |
Why?
|
Cell Survival | 1 | 1992 | 547 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1992 | 212 | 0.020 |
Why?
|
Plague | 1 | 1990 | 23 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1992 | 233 | 0.020 |
Why?
|
Dexamethasone | 1 | 1990 | 191 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 1992 | 321 | 0.020 |
Why?
|
Rosette Formation | 2 | 1980 | 12 | 0.020 |
Why?
|
Leukocyte Count | 2 | 1980 | 94 | 0.020 |
Why?
|
Dietary Fats, Unsaturated | 1 | 1989 | 23 | 0.020 |
Why?
|
Receptors, Leukotriene B4 | 1 | 1988 | 3 | 0.020 |
Why?
|
Ionophores | 1 | 1988 | 10 | 0.020 |
Why?
|
Vanadates | 1 | 1988 | 7 | 0.020 |
Why?
|
Prostaglandins D | 1 | 1988 | 1 | 0.020 |
Why?
|
Prostaglandins E | 1 | 1988 | 8 | 0.020 |
Why?
|
Hypersensitivity, Immediate | 1 | 1988 | 8 | 0.020 |
Why?
|
Monensin | 1 | 1988 | 4 | 0.020 |
Why?
|
Immunosorbent Techniques | 1 | 1988 | 10 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 1988 | 50 | 0.020 |
Why?
|
Random Allocation | 1 | 1988 | 198 | 0.020 |
Why?
|
Affinity Labels | 1 | 1988 | 9 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1988 | 58 | 0.020 |
Why?
|
Histamine | 1 | 1988 | 27 | 0.020 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2007 | 7 | 0.020 |
Why?
|
Drug Synergism | 2 | 1986 | 132 | 0.020 |
Why?
|
Biological Transport | 1 | 1988 | 289 | 0.020 |
Why?
|
Intracellular Fluid | 1 | 1987 | 32 | 0.020 |
Why?
|
Immunophenotyping | 2 | 1998 | 191 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 422 | 0.020 |
Why?
|
Protein Kinases | 1 | 1988 | 139 | 0.020 |
Why?
|
Receptors, Complement | 1 | 1986 | 17 | 0.020 |
Why?
|
Ehrlichiosis | 1 | 2006 | 6 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2013 | 617 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 1988 | 286 | 0.020 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1986 | 33 | 0.020 |
Why?
|
Neoplasms | 1 | 1996 | 1224 | 0.020 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1986 | 17 | 0.020 |
Why?
|
Lymphocytes | 2 | 1984 | 194 | 0.020 |
Why?
|
Chemotaxis | 2 | 1990 | 47 | 0.020 |
Why?
|
Hexosaminidases | 1 | 1985 | 7 | 0.020 |
Why?
|
NADPH Oxidases | 1 | 1986 | 64 | 0.020 |
Why?
|
Substrate Specificity | 2 | 2004 | 320 | 0.020 |
Why?
|
Drug Combinations | 1 | 1986 | 140 | 0.020 |
Why?
|
Disease Progression | 1 | 2010 | 1038 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 1985 | 80 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 1986 | 183 | 0.020 |
Why?
|
Patient Selection | 1 | 2007 | 443 | 0.020 |
Why?
|
Adolescent | 5 | 1998 | 5897 | 0.010 |
Why?
|
Silicon Dioxide | 1 | 2005 | 59 | 0.010 |
Why?
|
Pseudomonas Infections | 1 | 1984 | 50 | 0.010 |
Why?
|
Propionibacterium | 1 | 1984 | 5 | 0.010 |
Why?
|
Bacteroides | 1 | 1984 | 9 | 0.010 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1984 | 20 | 0.010 |
Why?
|
Adenylyl Cyclases | 1 | 1984 | 21 | 0.010 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2004 | 9 | 0.010 |
Why?
|
Probability | 1 | 2004 | 171 | 0.010 |
Why?
|
Subcellular Fractions | 2 | 1981 | 66 | 0.010 |
Why?
|
Stereoisomerism | 1 | 2004 | 68 | 0.010 |
Why?
|
C-Reactive Protein | 2 | 1998 | 167 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1985 | 351 | 0.010 |
Why?
|
Surface Properties | 1 | 2005 | 270 | 0.010 |
Why?
|
Peptide Library | 1 | 2004 | 35 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 1984 | 50 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 322 | 0.010 |
Why?
|
Blood Proteins | 2 | 1981 | 72 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1983 | 24 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1983 | 90 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 402 | 0.010 |
Why?
|
Particle Size | 1 | 2005 | 397 | 0.010 |
Why?
|
Valinomycin | 1 | 1982 | 3 | 0.010 |
Why?
|
Tritium | 1 | 1982 | 21 | 0.010 |
Why?
|
Health Personnel | 1 | 2006 | 340 | 0.010 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2004 | 147 | 0.010 |
Why?
|
Gold | 1 | 2005 | 226 | 0.010 |
Why?
|
Acetylglucosamine | 1 | 1982 | 11 | 0.010 |
Why?
|
Absorption | 1 | 1982 | 14 | 0.010 |
Why?
|
Bacteroides fragilis | 1 | 1982 | 5 | 0.010 |
Why?
|
Phospholipases | 1 | 1981 | 9 | 0.010 |
Why?
|
Phospholipases A | 1 | 1981 | 11 | 0.010 |
Why?
|
Cathepsins | 1 | 1982 | 32 | 0.010 |
Why?
|
Polysaccharides, Bacterial | 1 | 1982 | 43 | 0.010 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2001 | 5 | 0.010 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2001 | 4 | 0.010 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2001 | 8 | 0.010 |
Why?
|
Synovial Membrane | 1 | 2001 | 19 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2004 | 1022 | 0.010 |
Why?
|
Chondrocytes | 1 | 2001 | 42 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2001 | 39 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 2001 | 60 | 0.010 |
Why?
|
Meningitis | 2 | 1998 | 18 | 0.010 |
Why?
|
Centrifugation | 1 | 1980 | 10 | 0.010 |
Why?
|
Cell Aggregation | 1 | 1980 | 22 | 0.010 |
Why?
|
Nitroblue Tetrazolium | 1 | 1979 | 8 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1979 | 17 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1980 | 252 | 0.010 |
Why?
|
Neutropenia | 1 | 1980 | 66 | 0.010 |
Why?
|
Cytochrome c Group | 2 | 1991 | 24 | 0.010 |
Why?
|
Brain | 1 | 1988 | 1485 | 0.010 |
Why?
|
Gene Deletion | 1 | 2001 | 298 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1986 | 1536 | 0.010 |
Why?
|
Penicillin Resistance | 1 | 1979 | 8 | 0.010 |
Why?
|
Streptococcus | 1 | 1979 | 17 | 0.010 |
Why?
|
Penicillins | 1 | 1979 | 28 | 0.010 |
Why?
|
Glycoproteins | 1 | 1980 | 192 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1979 | 29 | 0.010 |
Why?
|
Immunization Schedule | 1 | 1998 | 20 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1979 | 77 | 0.010 |
Why?
|
Dinoprostone | 2 | 1989 | 42 | 0.010 |
Why?
|
Naproxen | 1 | 1978 | 7 | 0.010 |
Why?
|
Regional Medical Programs | 1 | 1998 | 6 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1978 | 22 | 0.010 |
Why?
|
Clinical Medicine | 1 | 1998 | 16 | 0.010 |
Why?
|
Nitrates | 1 | 1998 | 20 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1978 | 35 | 0.010 |
Why?
|
Indomethacin | 1 | 1978 | 20 | 0.010 |
Why?
|
Lactoferrin | 1 | 1978 | 40 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 90 | 0.010 |
Why?
|
Career Mobility | 1 | 1998 | 60 | 0.010 |
Why?
|
Research Personnel | 1 | 1998 | 85 | 0.010 |
Why?
|
Cricetinae | 1 | 1998 | 376 | 0.010 |
Why?
|
Genetic Linkage | 2 | 1991 | 101 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 1997 | 30 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1996 | 52 | 0.010 |
Why?
|
Etanercept | 1 | 1996 | 31 | 0.010 |
Why?
|
Societies, Medical | 1 | 1998 | 326 | 0.010 |
Why?
|
Program Evaluation | 1 | 1998 | 479 | 0.010 |
Why?
|
Neurocognitive Disorders | 1 | 1975 | 6 | 0.010 |
Why?
|
Prednisone | 1 | 1975 | 79 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 1975 | 56 | 0.010 |
Why?
|
Curriculum | 1 | 1998 | 543 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1975 | 156 | 0.010 |
Why?
|
Phytohemagglutinins | 1 | 1992 | 14 | 0.010 |
Why?
|
Concanavalin A | 1 | 1992 | 40 | 0.010 |
Why?
|
X Chromosome | 1 | 1991 | 44 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1990 | 20 | 0.010 |
Why?
|
RNA Splicing | 1 | 1991 | 161 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 1990 | 128 | 0.010 |
Why?
|
Base Sequence | 1 | 1991 | 1309 | 0.010 |
Why?
|
Fish Oils | 1 | 1989 | 43 | 0.000 |
Why?
|
Prostaglandin D2 | 1 | 1988 | 4 | 0.000 |
Why?
|
RNA | 1 | 1991 | 402 | 0.000 |
Why?
|
Age Factors | 1 | 1991 | 1518 | 0.000 |
Why?
|
DNA | 1 | 1991 | 787 | 0.000 |
Why?
|
Gene Expression | 1 | 1990 | 805 | 0.000 |
Why?
|
Receptors, Complement 3b | 1 | 1986 | 13 | 0.000 |
Why?
|
Radioligand Assay | 1 | 1986 | 24 | 0.000 |
Why?
|
Phenotype | 1 | 1990 | 1153 | 0.000 |
Why?
|
Granulocytes | 1 | 1986 | 66 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1990 | 1291 | 0.000 |
Why?
|
Uncoupling Agents | 1 | 1984 | 3 | 0.000 |
Why?
|
Enzyme Activation | 1 | 1984 | 351 | 0.000 |
Why?
|
Cathepsin G | 1 | 1982 | 1 | 0.000 |
Why?
|
Bacteroides Infections | 1 | 1982 | 5 | 0.000 |
Why?
|
Phospholipases A2 | 1 | 1981 | 12 | 0.000 |
Why?
|
Ferritins | 1 | 1982 | 32 | 0.000 |
Why?
|
Angiotensin II | 1 | 1982 | 24 | 0.000 |
Why?
|
Permeability | 1 | 1981 | 47 | 0.000 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 1981 | 54 | 0.000 |
Why?
|
Serine Endopeptidases | 1 | 1982 | 77 | 0.000 |
Why?
|
Endoplasmic Reticulum | 1 | 1981 | 168 | 0.000 |
Why?
|
Sex Chromosomes | 1 | 1980 | 8 | 0.000 |
Why?
|
Immune Adherence Reaction | 1 | 1980 | 1 | 0.000 |
Why?
|
Kartagener Syndrome | 1 | 1980 | 8 | 0.000 |
Why?
|
Immunoglobulin E | 1 | 1980 | 85 | 0.000 |
Why?
|
Burns | 1 | 1980 | 43 | 0.000 |
Why?
|
Penicillin G | 1 | 1979 | 5 | 0.000 |
Why?
|
Rheumatic Fever | 1 | 1979 | 3 | 0.000 |
Why?
|
Streptomycin | 1 | 1979 | 12 | 0.000 |
Why?
|
Gentamicins | 1 | 1979 | 22 | 0.000 |
Why?
|
Psychoses, Substance-Induced | 1 | 1975 | 5 | 0.000 |
Why?
|
Azathioprine | 1 | 1975 | 22 | 0.000 |
Why?
|
Child, Preschool | 1 | 1980 | 1824 | 0.000 |
Why?
|
Psychotropic Drugs | 1 | 1975 | 83 | 0.000 |
Why?
|